Annals of dermatology · 2026
Clinic-Based Proportion of Psoriatic Arthritis and HLA-B27 Distribution in Korean Psoriasis Patients: A Retrospective Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jung Yeon Woo, Hwang Shinwon, Kim Tae-Gyun
Аннотация
BACKGROUND: Psoriatic arthritis (PsA) develops in up to one-third of patients with psoriasis over the disease course, and the genetic factors are thought to modulate susceptibility. Although HLA-B27 has long been implicated in PsA, its clinical utility for identifying PsA in East Asian populations remains uncertain.
OBJECTIVE: We aimed to estimate the clinic-based prevalence of PsA among Korean psoriatic patients, and to evaluate the diagnostic value of HLA-B27, along with other clinical markers, for PsA.
METHODS: We conducted a retrospective, cross-sectional study of 209 patients with psoriasis who presented for their initial dermatology clinic visit at a tertiary referral center.
RESULTS: The clinic-based prevalence of PsA was 13.9%. HLA-B27 positivity did not show significant difference between patients with PsA and psoriasis not fulfilling Classification Criteria for Psoriatic Arthritis criteria (13.8% vs. 7.8%) and was not associated with PsA or cutaneous disease severity in multivariable analyses. In contrast, nail dystrophy and elevated C-reactive protein (CRP) levels were independently associated with PsA. In this cohort, HLA-B27 demonstrated limited predictive value, whereas nail involvement and elevated CRP levels emerged as more reliable indicators of joint involvement.
CONCLUSION: In this dermatology-based cohort of unselected Korean patients with psoriasis at the initial clinic visit, routine HLA-B27 testing showed limited utility as a screening tool for PsA, whereas nail involvement and elevated CRP levels served as more practical clinical cues for closer joint involvement.
OBJECTIVE: We aimed to estimate the clinic-based prevalence of PsA among Korean psoriatic patients, and to evaluate the diagnostic value of HLA-B27, along with other clinical markers, for PsA.
METHODS: We conducted a retrospective, cross-sectional study of 209 patients with psoriasis who presented for their initial dermatology clinic visit at a tertiary referral center.
RESULTS: The clinic-based prevalence of PsA was 13.9%. HLA-B27 positivity did not show significant difference between patients with PsA and psoriasis not fulfilling Classification Criteria for Psoriatic Arthritis criteria (13.8% vs. 7.8%) and was not associated with PsA or cutaneous disease severity in multivariable analyses. In contrast, nail dystrophy and elevated C-reactive protein (CRP) levels were independently associated with PsA. In this cohort, HLA-B27 demonstrated limited predictive value, whereas nail involvement and elevated CRP levels emerged as more reliable indicators of joint involvement.
CONCLUSION: In this dermatology-based cohort of unselected Korean patients with psoriasis at the initial clinic visit, routine HLA-B27 testing showed limited utility as a screening tool for PsA, whereas nail involvement and elevated CRP levels served as more practical clinical cues for closer joint involvement.